Kyushu University, a national university in Japan (Fukuoka-shi, Fukuoka, President: Chiharu Kubo) (Kyushu University) and IP Bridge, Inc. and its subsidiary Godo Kaisha IP Bridge 1 (IP Fund) (collectively “IP Bridge”) (Chiyoda-ku, Tokyo, President: Shigeharu Yoshii) have entered into joint research and development of drug discovery in the pharmaceutical industries using engineering technology based on industry-university cooperation.
In particular, Kyushu University and IP Bridge will study medical properties which are physically and chemically sensitive by using microcapsule technology (*1) consisting of Silica porous materials (*2) which has been studied by Kishida, Ph.D., a Professor of Kyushu University. The joint research aims to develop a new drug delivery system and realize the microcapsule technology through the joint efforts of IP Bridge and Kyushu University in cooperation with pharmaceutical companies to promote open-innovation.
IP Bridge will continue to contribute to the development of industries by supporting universities and enterprises in adapting research results (technologies and intellectual properties) of universities to industrial enterprises, thereby allowing enterprises to accelerate their growth and enhance their competitive advantage and profitability.
*1 Technology for forming structure capsuling substances
*2 Silicon dioxide with nanoscale pores